Aisling Capital Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-333,333
| Closed | -$4.63M | – | 14 |
|
|
2020
Q1 | $4.63M | Hold |
333,333
| – | – | 2.02% | 7 |
|
|
2019
Q4 | $3.37M | Hold |
333,333
| – | – | 1.29% | 10 |
|
|
2019
Q3 | $3.03M | Hold |
333,333
| – | – | 1.58% | 11 |
|
|
2019
Q2 | $2.65M | Hold |
333,333
| – | – | 1.13% | 12 |
|
|
2019
Q1 | $4.16M | Sell |
333,333
-203,180
| -38% | -$2.54M | 3.17% | 10 |
|
|
2018
Q4 | $5.78M | Buy |
+536,513
| New | +$5.78M | 6.09% | 7 |
|